Latest Insider Transactions at Eli Lilly & CO (LLY)
This section provides a real-time view of insider transactions for Eli Lilly & CO (LLY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ELI LILLY & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ELI LILLY & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 03
2024
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
750
-9.52%
|
$614,250
$819.47 P/Share
|
|
Jun 03
2024
|
Johna Norton EVP, Global Quality |
SELL
Open market or private sale
|
Direct |
7,056
-21.72%
|
$5,778,864
$819.38 P/Share
|
|
Jun 01
2024
|
Diogo Rau EVP & CIDO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,045
-21.53%
|
$2,496,900
$820.34 P/Share
|
|
Jun 01
2024
|
Diogo Rau EVP & CIDO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,300
+30.81%
|
-
|
|
May 31
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
22,206
-0.01%
|
$18,253,332
$822.63 P/Share
|
|
May 29
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
130,385
-0.02%
|
$105,872,620
$812.44 P/Share
|
|
May 28
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
2,052
-0.0%
|
$1,660,068
$809.0 P/Share
|
|
May 24
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
92,563
-0.09%
|
$74,883,467
$809.21 P/Share
|
|
May 23
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
50,767
-0.0%
|
$41,222,804
$812.27 P/Share
|
|
May 22
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
12,974
-0.01%
|
$10,431,096
$804.18 P/Share
|
|
May 21
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
186,259
-0.02%
|
$150,497,272
$808.57 P/Share
|
|
May 20
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.6%
|
$10,179
$783.18 P/Share
|
|
May 20
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.86%
|
$10,179
$783.18 P/Share
|
|
May 20
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.45%
|
$9,396
$783.18 P/Share
|
|
May 20
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.12%
|
$14,877
$783.18 P/Share
|
|
May 20
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.03%
|
$11,745
$783.18 P/Share
|
|
Apr 15
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.61%
|
$9,750
$750.77 P/Share
|
|
Apr 15
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.03%
|
$12,000
$750.77 P/Share
|
|
Apr 15
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.87%
|
$9,750
$750.77 P/Share
|
|
Apr 15
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.49%
|
$9,750
$750.77 P/Share
|
|
Apr 15
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
20
+0.13%
|
$15,000
$750.77 P/Share
|
|
Mar 18
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.12%
|
$14,478
$762.66 P/Share
|
|
Mar 18
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.61%
|
$9,906
$762.66 P/Share
|
|
Mar 18
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.03%
|
$11,430
$762.66 P/Share
|
|
Mar 18
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.88%
|
$9,906
$762.66 P/Share
|
|
Mar 18
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.49%
|
$9,906
$762.66 P/Share
|
|
Mar 11
2024
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
750
-8.69%
|
$564,750
$753.6 P/Share
|
|
Feb 20
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.89%
|
$9,815
$755.66 P/Share
|
|
Feb 20
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.62%
|
$9,815
$755.66 P/Share
|
|
Feb 20
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
20
+0.13%
|
$15,100
$755.66 P/Share
|
|
Feb 20
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.03%
|
$12,080
$755.66 P/Share
|
|
Feb 20
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.5%
|
$9,815
$755.66 P/Share
|
|
Feb 16
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
169,684
-0.01%
|
$132,014,152
$778.8 P/Share
|
|
Feb 15
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
50,316
-0.02%
|
$38,290,476
$761.34 P/Share
|
|
Feb 12
2024
|
Anne E. White EVP & Pres, Lilly Neuroscience |
BUY
Grant, award, or other acquisition
|
Direct |
5,363
+7.56%
|
$3,952,531
$737.26 P/Share
|
|
Feb 12
2024
|
Jacob Van Naarden EVP & Pres., Lilly Oncology |
BUY
Grant, award, or other acquisition
|
Direct |
2,369
+12.79%
|
$1,745,953
$737.26 P/Share
|
|
Feb 12
2024
|
Eric Dozier EVP, Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,336
+15.67%
|
$984,632
$737.26 P/Share
|
|
Feb 12
2024
|
Eric Dozier EVP, Chief People Officer |
SELL
Bona fide gift
|
Direct |
408
-6.52%
|
-
|
|
Feb 12
2024
|
Daniel Skovronsky EVP, CSO & Pres. LRL & LLY Imm |
BUY
Grant, award, or other acquisition
|
Direct |
12,910
+9.45%
|
$9,514,670
$737.26 P/Share
|
|
Feb 12
2024
|
Anat Ashkenazi EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
4,210
+9.05%
|
$3,102,770
$737.26 P/Share
|
|
Feb 12
2024
|
Donald A Zakrowski SVP, Finance, & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
1,254
+12.69%
|
$924,198
$737.26 P/Share
|
|
Feb 12
2024
|
David A Ricks President, Chair, and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
38,392
+7.42%
|
$28,294,904
$737.26 P/Share
|
|
Feb 12
2024
|
Anat Hakim EVP, GC & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
5,815
+16.02%
|
$4,285,655
$737.26 P/Share
|
|
Feb 12
2024
|
Patrik Jonsson EVP&Pres, CardMetHlth, LLY USA |
BUY
Grant, award, or other acquisition
|
Direct |
5,362
+10.74%
|
$3,951,794
$737.26 P/Share
|
|
Feb 12
2024
|
Edgardo Hernandez EVP & Pres., Mfg. Operations |
BUY
Grant, award, or other acquisition
|
Direct |
2,821
+8.68%
|
$2,079,077
$737.26 P/Share
|
|
Feb 12
2024
|
Ilya Yuffa EVP & President, LLY Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
4,790
+19.48%
|
$3,530,230
$737.26 P/Share
|
|
Feb 12
2024
|
Alonzo Weems EVP, ERM & CECO |
BUY
Grant, award, or other acquisition
|
Direct |
951
+10.68%
|
$700,887
$737.26 P/Share
|
|
Feb 12
2024
|
Johna Norton EVP, Global Quality |
BUY
Grant, award, or other acquisition
|
Direct |
1,668
+4.88%
|
$1,229,316
$737.26 P/Share
|
|
Feb 09
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
206,257
-0.03%
|
$153,042,694
$742.88 P/Share
|
|
Feb 08
2024
|
David A Ricks President, Chair, and CEO |
SELL
Bona fide gift
|
Direct |
956
-0.22%
|
-
|